Multiple genetic alterations in vitamin K epoxide reductase complex subunit 1 gene (VKORC1) can explain the high dose requirement during oral anticoagulation in humans - Bodin, L; Perdu, J; Diry, M (J Thromb Haemost, 2008)
et al.